Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker to Predict the Response to Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients: a Transcriptomic Study

NCT02629796 is registered in ClinicalTrials.gov with Fondation Ophtalmologique Adolphe de Rothschild as lead sponsor.

NCT NCT02629796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02629796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker to Predict the Response to Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients: a Transcriptomic Study
Lead sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Phase
Observational
Overall status
Completed
Start date
April 16, 2014
Completion date
November 15, 2021
Enrollment
44 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

cidp